Danaher (FRA:DAP) Shareholder Yield % : 1.37% (As of Mar. 2026) — 73% Above Median


FRA:DAP Danaher Corp FRA:DAP
76 GF Score
Price €169.00
GF Value €207.79
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Danaher Shareholder Yield %?

Danaher FRA:DAP -0.03% 76 Shareholder Yield % is 1.37% as of Mar. 2026, which is 73% above its 10-year median of 0.79. GuruFocus rates FRA:DAP with a GF Score™ of 76/100 and a GF Value™ of €207.79 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Danaher ranks better than 61.88% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, Danaher's Shareholder Yield % was 1.37%.


Danaher  (FRA:DAP) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Danaher Shareholder Yield % Related Terms


Danaher Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Danaher's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danaher Shareholder Yield % Chart

Danaher Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shareholder Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.79 1.22 0.47 5.73 2.34

Danaher Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shareholder Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.32 3.85 4.19 2.34 1.36

FRA:DAP vs TMO, IDXX, A: Shareholder Yield % Comparison

For the Diagnostics & Research subindustry, Danaher's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danaher Shareholder Yield % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Danaher's Shareholder Yield % falls into.


FRA:DAP
76GF Score
Danaher Corp FRA:DAP
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Danaher Shareholder Yield % Calculation

Danaher's Shareholder Yield % for the quarter that ended in Mar. 2026 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0.71 %+1.43 %+0.21 %
=2.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of 1.37% mean?
Danaher (FRA:DAP) has a Shareholder Yield % of 1.37% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Danaher and its competitors. This is 73% above median its historical median of 0.79. According to the industry distribution chart, Danaher ranks #77 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 38.1%.
Is Danaher's Shareholder Yield % too high?
Danaher's current Shareholder Yield % of 1.37% is 73% above median its 10-year median of 0.79. Based on the distribution chart, Danaher ranks #77 out of 202 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Danaher has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Danaher's Shareholder Yield % compare to TMO and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Danaher ranks #77 out of 202 companies for Shareholder Yield %. This puts Danaher in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Diagnostics & Research company?
A good Shareholder Yield % depends on the Medical Diagnostics & Research industry context. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Danaher and its competitors. Danaher's current Shareholder Yield % is 1.37%, which is 73% above median its own 10-year median of 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danaher stock overvalued right now?
Based on GuruFocus' analysis, Danaher (FRA:DAP) is currently considered Modestly Undervalued. The stock's GF Value™ is €207.79, compared to a current price of €169.00 — trading 18.7% below its estimated fair value. The current Shareholder Yield % is 1.37%, which is 73% above median its 10-year median of 0.79. Danaher's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Danaher (FRA:DAP), the current Shareholder Yield % is 1.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Danaher (FRA:DAP) Overvalued in 2026?

Based on GuruFocus' analysis, Danaher stock appears to be undervalued. The current stock price of €169.00 is trading 18.7% below its estimated GF Value™ of €207.79. GuruFocus considers Danaher to be Modestly Undervalued.

Key valuation signals for FRA:DAP:

  • Shareholder Yield %: 1.37% (73% above median its 10-year median of 0.79)
  • GF Value™: €207.79 vs. price of €169.00 (18.7% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the FRA:DAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Danaher Business Description

Address 2200 Pennsylvania Avenue, NW, Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
76GF Score

Get the complete analysis for FRA:DAP

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€169.00
Price
€207.79
GF Value